Exchange Announcement • 12 Dec 2024 19:45
Exchange Announcement • 11 Dec 2024 20:46
Exchange Announcement • 11 Dec 2024 06:28
Exchange Announcement • 11 Dec 2024 06:13
Exchange Announcement • 19 Nov 2024 21:01
ENTITY
ImmunityBio (IBRX US)
ImmunityBio (IBRX US)
1
Analysis
Health Care • United States
ImmunityBio, Inc. operates as a biotechnology company. The Company focuses on developing cell and immunotherapy products for the treatment of cancers, infectious, and inflammatory diseases. ImmunityBio serves customers in the United States.
more
x